Low-count whole-body PET denoising with deep learning in a multicenter, multi-tracer and externally validated study.

Journal: European journal of nuclear medicine and molecular imaging
Published Date:

Abstract

BACKGROUND: Positron Emission Tomography (PET) is a powerful diagnostic tool, but its availability, high cost and radiation burden limit its accessibility. Deep learning-based denoising offers a potential solution by enabling low-count PET scans, reducing tracer dose or scan time without compromising diagnostic utility. However, clinical validation of such approaches across different scanner technologies and radiotracers remains limited. METHODS: We conducted a multicenter, blinded evaluation of NUCLARITY, a deep learning-based denoising software, using PET data from three European hospitals. Data included 65 scans acquired with [1⁸F]FDG, [1⁸F]PSMA, [68 Ga]PSMA, and [68 Ga]DOTATATE on GE and Siemens systems not seen during model training. Low-count scans (50% simulated) were denoised and compared to full-count clinical scans. Image quality was assessed using RMSE, PSNR, and SSIM. Six nuclear physicians evaluated diagnostic image quality (DIQ), diagnostic confidence (DC), and lesion detection across six anatomical regions. Lesion quantification was compared using SUVmean, SUVmax, and MTV. RESULTS: Low-count enhanced (LCE) scans showed improved quantitative image quality metrics compared to unenhanced low-count scans (higher PSNR/SSIM, lower RMSE). Across 243 lesions, SUVmean and SUVmax showed high concordance between standard-count (SC) and LCE scans (CCC = 1.00 and 0.99, respectively). Diagnostic image quality and confidence were slightly lower on LCE versus SC scans, but only one reader indicated a clear preference for SC. Sensitivity and specificity for lesion detection in LCE scans were 99% and 99%, respectively, with interscan agreement exceeding inter-reader variability. CONCLUSIONS: This is the first blinded, multicenter reader study evaluating a PET denoising algorithm in a European clinical setting across multiple tracers, incorporating unseen scanner technologies. The denoising algorithm demonstrated robust generalizability and preserved diagnostic accuracy on 50% count data. These findings support the clinical adoption of deep learning-based PET denoising to reduce dose or scan time for four commonly used tracers.

Authors

  • Justine Maes
    Division of Nuclear Medicine, University Hospitals UZ Leuven, Louvain, Belgium.
  • Charles Carron
    Division of Nuclear Medicine, University Hospitals UZ Leuven, Louvain, Belgium.
  • Simon DeKeyser
    Nuclivision, Ghent, Belgium.
  • Tomas Brants
    Nuclivision, Ghent, Belgium.
  • Vicky De Ridder
    Nuclivision, Ghent, Belgium.
  • Amine Chaouki
    Department of Nuclear Medicine, Chirec Hospital Group, Brussels, Belgium.
  • Camille Steenhout
    Division of Nuclear Medicine and Oncological Imaging, CHU de Liège, Liège, Belgium.
  • Stefaan Vandenberghe
    Department of Electronics and Information Systems, Medical Image and Signal Processing (MEDISIP), Ghent University, Ghent, Belgium.
  • Yves D'Asseler
    Department of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
  • Laurens Raes
    Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels, Belgium.
  • Azzam Abdalla Ibrahim
    Department of Nuclear Medicine, VieCurie Medisch Centrum, Venlo, The Netherlands.
  • Gerard Moulin-Romsee
    Department of Nuclear Medicine, AZ Monica, Antwerp, Belgium.
  • Isaac Kargar Samani
    Department of Nuclear Medicine, Centre Hospitalier EpiCURA, Baudour, Belgium.
  • Ludovic D'hulst
    a Division of Nuclear Medicine and Department of Imaging and pathology , University Hospitals Leuven and KU Leuven , Leuven , Belgium.
  • Sezgin Ustmert
    Department of Nuclear Medicine, AZ Groeninge, Kortrijk, Belgium.
  • Maarten Larmuseau
    Nuclivision, Ghent, Belgium. [email protected].

Keywords

No keywords available for this article.